This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $93,904.60, is for the provision of Verzenio 100 mg tablets, a medication used to treat certain types of breast cancer. The contract is a firm fixed-price arrangement with an ultimate completion date of October 23, 2024. This contract award is not designated as a set-aside. AmerisourceBergen is the prime contractor, and the contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 1/22/25, 12:55 AM